Part D/Prescription Drugs – Page 52 – medicarereport.org

Friday, September 11, 2026

Latest:

Aging CMS Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook March 20, 2023March 20, 2023 medicare, Medicare Advantage, Medicare Part D

Here are the Medicare basics

More than 10,000 people turn 65 every day in the United States. Knowing your options for health care are more

CDC Health Care - General Part D/Prescription Drugs Substance Abuse

Arlene Sharp March 17, 2023March 17, 2023 CDC, Opiods, Presecription drugs

New CDC Opioid Guidelines: Too Little, Too Late for Chronic Pain Patients?

By Sam Whitehead and Andy Miller for Kaiser Health News on March 15, 2023 Jessica Layman estimates she has called

Aging Health Care - General Medicare - General Part D/Prescription Drugs

Arlene Sharp March 13, 2023March 13, 2023 Medicare Part D, Prescription drug coverage, weight loss drugs

Covering new weight loss drugs could strain Medicare, policy experts warn

By Elaine Chen for Stat News on March 11, 2023 The emergence of highly effective obesity drugs has spurred renewed

Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook March 10, 2023 IRMAA, medicare, Medicare Advantage, Medicare Part D

Hit with that extra premium for Medicare?

The Medicare Income-Related Monthly Adjustment Amount (IRMAA) is an amount you may pay in addition to your Part B or

Health Care Finance Part D/Prescription Drugs Price Transparency

Eileen Cook March 9, 2023March 9, 2023 Big Pharma, Healthcare Costs, Insulin, Insurers, Medicare Insulin Cost-sharing, PBM

Why Does Insulin Cost So Much? Big Pharma Isn’t the Only Player Driving Prices

(By Arthur Allen for Kaiser Health News) Eli Lilly & Co.’s announcement that it is slashing prices for its major

Part D/Prescription Drugs

Eileen Cook March 8, 2023March 8, 2023 Diabetes Treatment, Ozempic

5 Ozempic updates

(By Paige Twenter for Becker’s Hospital Review ) Ozempic, a diabetes treatment that has caught the attention of Elon Musk,

CMS Medicare - General Part D/Prescription Drugs

Eileen Cook March 7, 2023March 7, 2023 CMS, medicare, Medicare Drug Price Negotiation Program, Medicare Part D

Biden proposes expanding Medicare drug negotiation program

(By Rachel Cohrs for ST A T) WASHINGTON — The Biden administration will propose expanding Democrats’ new drug pricing law

CMS Part D/Prescription Drugs

Eileen Cook March 3, 2023March 3, 2023 CMS, Inflation Reduction Act of 2022, Medicare Part A, Medicare Part B, Medicare Part D

CMS Drug Spending Dashboards and the Inflation Reduction Act

(Source - www.cms.gov/blog) The Centers for Medicare & Medicaid Services released the annual update to the Drug Spending Dashboards with

FDA Legislative Update Part D/Prescription Drugs

Eileen Cook March 3, 2023March 3, 2023 FDA, FDA’s accelerated approval, Medicare Part D

FDA has new leverage over companies looking for a quicker drug approval

(By Sydney Lupkin for NPR) The huge spending bill that became law last December also included fixes to a problem

CMS Medicare - General Medicare Advantage Medigap Part D/Prescription Drugs

Eileen Cook March 2, 2023March 2, 2023 CMS, medicare, Medicare Advantage, Medicare Part D, Medigap

More insurance brokers would choose traditional Medicare over Medicare Advantage: Report

(By Rylee Wilson for Becker’s Hospital Review ) More insurance brokers said they would enroll in traditional Medicare over Medicare